Cart
sales@molnova.com
DMU2105
CAS No. 1031063-36-1
DMU2105( —— )
Catalog No. M22627 CAS No. 1031063-36-1
DMU2105 is a specific CYP1B1 inhibitor(CYP1B1 and CYP1A1 with IC50 of 10 nM and 742 nM, respectively)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 2MG | 59 | In Stock |
|
| 5MG | 86 | In Stock |
|
| 10MG | 126 | In Stock |
|
| 25MG | 227 | In Stock |
|
| 50MG | 335 | In Stock |
|
| 100MG | 502 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDMU2105
-
NoteResearch use only, not for human use.
-
Brief DescriptionDMU2105 is a specific CYP1B1 inhibitor(CYP1B1 and CYP1A1 with IC50 of 10 nM and 742 nM, respectively)
-
DescriptionDMU2105 is a specific CYP1B1 inhibitor(CYP1B1 and CYP1A1 with IC50 of 10 nM and 742 nM, respectively).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP1B1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1031063-36-1
-
Formula Weight259.3
-
Molecular FormulaC18H13NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(\C=C\c1ccc2ccccc2c1)c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Horley N J , Beresford K J M , Chawla T , et al. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines[J]. European Journal of Medicinal Chemistry, 2017, 129:159-174.
molnova catalog
related products
-
Anemosapogenin
Anemosapogenin shows potent anti-tumor effect in vivo, but it has some toxicity, structure modification should be needed.
-
AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor(IC50 :1.9 nM). AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
-
Furafylline
Furafylline is a selective inhibitor of human cytochrome P450 (CYP)1A2 (IC50 : 0.07 μM)
